Key Takeaways:
Healthpeak Properties Inc. (DOC) reported first-quarter funds from operations of $0.45 per share, topping Wall Street estimates and prompting the healthcare REIT to lift its 2026 forecast.
"The results validate our strategy and the strong underlying fundamentals in our life science and medical office portfolios," Chief Financial Officer Kelvin Moses said on the company's earnings call. Moses also highlighted a strengthened balance sheet following a recent IPO and a new $400 million term loan facility.
The company's Q1 performance beat the average analyst estimate of $0.43 per share for funds from operations. Healthpeak also raised its full-year 2026 FFO guidance to a range of $1.71 to $1.75 per share, up from its prior outlook. The midpoint of the new range, $1.73, is largely in line with the analyst consensus of $1.74.
Shares of Healthpeak surged 13.6% to $18.76 in morning trading on May 6. The move was likely amplified by a short-covering rally, as short interest in the stock had increased by 96.5% over the past year to stand at 4.6% of the float. The broader market provided a tailwind, with the S&P 500 climbing more than 1%.
The strong results from Healthpeak were echoed by peers, lending sector-wide support. Ventas Inc. (VTR) reported a 9% increase in normalized FFO and raised its 2026 investment target, while Welltower Inc. (WELL) also beat expectations and raised its full-year guidance.
The guidance raise from Healthpeak suggests management is confident that the solid leasing activity and growth from its Janus Living IPO will continue. Investors will be watching for continued strength in same-store net operating income growth in the company's upcoming Q2 report.
This article is for informational purposes only and does not constitute investment advice.
